74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
West Pharmaceutical Services Inc
Closed
Sector Healthcare
210.49 3.52
Overview
Share price change
24h
Min
207.9
Max
210.49
Income | -5.9M 130M |
|---|---|
Sales | 1.9M 749M |
P/E Sector Avg | 30.313 73.394 |
EPS | 1.82 |
Dividend yield | 0.41 |
Profit margin | 17.374 |
EBITDA | -2.1M 203M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +46.51 upside |
Dividend yield Sector Avg | 0.41% 3.09% |
|---|---|
Next Earnings | 24 Apr 2025 |
Next Dividend date | 7 May 2025 |
Next Ex Dividend date | 30 Apr 2025 |
Market Cap | -10B 15B |
|---|---|
Previous open | 206.97 |
Previous close | 210.49 |
News Sentiment
By Acuity
90%
10%
373 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
West Pharmaceutical Services Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
West Pharmaceutical Services Inc Forecast
Price Target
By TipRanks
46.51% upside
12 Months Forecast
Average 309 USD 46.51%
High 400 USD
Low 250 USD
Based on 6 Wall Street analysts offering 12 month price targets forWest Pharmaceutical Services Inc - Dist in the last 3 months.
Sentiment
By Acuity
373 / 393 Healthcare
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
